NRX Pharmaceuticals annual revenue
2022
2023
2024
2025
NRX Pharmaceuticals Revenue Growth & History (NRXP)
NRX Pharmaceuticals reported $1.2M in revenue for fiscal 2025.
View full NRX Pharmaceuticals company overviewNRX Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.2M | $1.2M | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
NRX Pharmaceuticals quarterly revenue
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.1M | $1.1M | — |
| Q1 2026 | 2026-03-31 | $1.1M | $1.1M | — |
| Q4 2025 | 2025-12-31 | $983,000 | — | — |
| Q3 2025 | 2025-09-30 | $242,000 | $242,000 | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q3 2024 | 2024-09-30 | $0 | — | — |
NRX Pharmaceuticals revenue growth trends
NRX Pharmaceuticals's latest reported quarter, Q2 2026, generated $1.1M in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review NRX Pharmaceuticals source filings ↗